Search Results for NHS

Showing 1 – 25  of 37

England Reimbursement Profile By Vishal Patel - Published 18 September 2017

This profile summarizes the reimbursement process in England, presents key stakeholders and highlights what should be considered early in the development process.

Categories: Features, Europe, MHRA, NICE, Biologics and biotechnology, Drugs, Reimbursement

Tags: NICE, NHS, Reimbursement

UK Report Calls for Streamlining to Accelerate Access to Drugs by Four Years By Michael Mezher - Published 24 October 2016

The UK government on Monday released a new report on accelerated access, claiming the UK's National Health Service (NHS) could speed access to new drugs and devices by streamlining regulatory, health technology assessment (HTA) and reimbursement mechanisms.

Categories: News, Europe, MHRA, NICE, Biologics and biotechnology, Drugs, Government affairs, In vitro diagnostics, Medical Devices, Regulatory strategy, Reimbursement

Tags: National Health Service, NHS, Accelerated Access Pathway

NICE Backs Five New Drugs, Gives Conditional Recommendation to GSK's Benlysta By Michael Mezher - Published 22 June 2016

The UK's National Institute for Health and Care Excellence (NICE) on Wednesday issued recommendations for six drugs after agreeing to discounts with their respective manufacturers, clearing the drugs for use by the country's National Health Service (NHS).

Categories: News, Europe, NICE, Biologics and biotechnology, Drugs, Reimbursement, Submission and registration

Tags: Zykadia, Mekinist, Praluent, Repatha, Humira, Benlysta, NICE, NHS

UK Patients With NSCLC to get Early Access to Tagrisso By Michael Mezher - Published 07 December 2015

Patients in the UK with a specific form of non-small-cell lung cancer (NSCLC) will get early access to AstraZeneca's Tagrisso (osimertinib), following a positive opinion by the Medicines and Healthcare products Regulatory Agency (MHRA).

Categories: News, Europe, MHRA, Biologics and biotechnology, Clinical, Regulatory strategy, Submission and registration

Tags: Non-small-cell lung cancer, NSCLC, EGFR T790M mutation-positive lung cancer, Early Access to Medicines Scheme, EAMS, National Health Service, NHS, Tagrisso, osimertinib

UK Agencies Look to Overhaul Cancer Drugs Fund By Zachary Brennan - Published 19 November 2015

The National Health Service (NHS) of England and the National Institute for Health and Care Excellence (NICE) on Thursday introduced a new proposal to transform the £340 million ($520 million) Cancer Drugs Fund (CDF) to allow patients to have earlier access to new treatments while real-world evidence is still being collected.

Categories: News, Europe, EMA, MHRA, NICE, Biologics and biotechnology, Blood, Crisis management, Drugs, Government affairs, Preclinical, Quality, Reimbursement, Research and development

Tags: cancer drugs, biotech, NICE, NHS, UK cancer drugs, EMA

NICE to Work Earlier With Industry to Speed NHS Adoption of New Drugs, Devices By Zachary Brennan - Published 13 October 2015

The UK's National Institute for Health and Care Excellence (NICE) on Tuesday officially launched its Office for Market Access (OMA) to collaborate more closely with industry to accelerate the adoption of new drugs, devices and diagnostics by the National Health Service (NHS).

Categories: News, Europe, NICE, Biologics and biotechnology, Combination products, Drugs, Government affairs, Medical Devices, Postmarket surveillance, Reimbursement

Tags: NICE, NHS, Office for Market Access, health technology evaluations, cost-effectiveness studies

Leverage Purchasing Power to Save Billions on Medicines and Devices, NHS Urged By Michael Mezher - Published 12 June 2015

According to an independent report commissioned by the UK's Department of Health, the National Health Service (NHS) could save as much as £5 billion (GBP) per year by 2020 through medicines optimization and leveraging NHS buying power to save on medical devices and consumables.

Categories: Drugs, Ethics, Medical Devices, Reimbursement

Tags: National Health Service, NHS, Lord Carter, Evidence-based medicine

NHS Looks at Boosting Product Development in UK with Innovative Product Review By Michael Mezher - Published 12 March 2015

The UK’s National Health Service (NHS) is instituting a new program aimed at accelerating access to new healthcare products. The Innovative Medicines and Medical Technology Review will look at ways to optimize the environment for product development in the UK, “from proof of concept through regulation, cost-effectiveness assessment and adoption and diffusion.”

Categories: News, Europe, MHRA, NICE, Biologics and biotechnology, Drugs, Government affairs, Medical Devices, Regulatory strategy, Reimbursement, Research and development, Submission and registration

Tags: NHS, Innovative Medicines and Medical Technology Review

NICE Urges Review of Drug Evaluation Methodology By Louise Zornoza, RegLink News - Published 18 September 2014

Following public criticism of its rejection of a number of expensive cancer treatments, the UK’s health cost watchdog is calling for a review of the way new medicines are adopted by the National Health Service.  

Categories: News, Europe, Reimbursement

Tags: NICE, UK, NHS, National Health Service

NICE Assuming New Duties, Will Assist NHS With Use of Innovative Medical Devices By Louise Zornoza, RegLink - Published 02 May 2013

Categories: NICE

Tags: UK, NHS, medical device

NICE Green Lights IVD for Breast Cancer Diagnosis By Louise Zornoza, RegLink - Published 21 February 2013

Categories: Regulatory Update, NICE

Tags: Breast Cancer, CER, UK, NHS, diagnostic, IVD, draft guidance

UK's NICE Releases Draft Guidance on Diagnosis and Treatment of Hepatitis B By Louise Zornoza, RegLink - Published 18 January 2013

Categories: Regulatory Update, NICE

Tags: Draft Guideline, NHS, Hepatitis B, guideline

UK Clears New Bone Healing Device for NHS Use By Louise Zornoza, RegLink - Published 10 January 2013

Categories: NICE

Tags: EXOGEN, UK, NHS

Novartis Cystic Fibrosis Drug Cleared for NHS Use By Louise Zornoza, RegLink - Published 25 October 2012

Categories: NICE

Tags: Cystic Fibrosis, Forest, Novartis, Latest News, UK, NHS, guidance

Pfizer's Cyklokapron Green Lighted for Off-Label Use by NHS By Louise Zornoza, RegLink - Published 22 October 2012

Categories: NICE

Tags: Tranexamic Acid, Trauma, Cyklokapron, Pfizer, Off Label, Off-label, Latest News, NHS, guidance

Boehringer Ingelheim's Blot Clot Drug Cleared for NHS Use By Louise Zornoza, RegLink - Published 28 September 2012

Categories: Regulatory Update, NICE

Tags: Boehringer Ingelheim, Stroke, NHS, guidance

In Shakeup, UK Health Secretary Andrew Lansley Ousted By Alexander Gaffney - Published 04 September 2012

Tags: Hunt, Health Secretary, Health, Lansley, Latest News, UK, NHS

NHS to be Called Out if NICE Guidance Not Followed Published 30 August 2012

Categories: NICE, Drugs

Tags: David Stout, Paul Burstow, Latest News, UK, NHS

New Electrosurgery Device Cleared for NHS Use By Alexander Gaffney - Published 23 August 2012

Categories: NICE

Tags: Electrosurgery, Final Guidance, Latest News, NHS

UK Convenes Expert Panel to Assess New Regulatory Framework for Implants By Alexander Gaffney - Published 15 August 2012

Tags: DOH, Expert Panel, Implants, Breast Implant, PIP, Latest News, UK, NHS

UK NICE Gives Green Light to Servier's Procoralan for Chronic Heart Failure By Louise Zornoza, RegLink - Published 08 August 2012

Categories: Regulatory Update, NICE

Tags: ivabradine, Peocoralan, Heart Failure, Servier, UK, NHS, draft guidance

NICE Clears New Colposcopy Device for NHS Use By Louise Zornoza, RegLink - Published 02 August 2012

Categories: Regulatory Update, NICE

Tags: Colposcopy, NHS

UK: New Anti-clotting Drug Cleared for NHS Use By Louise Zornoza, RegLink - Published 26 July 2012

Categories: NICE, Reimbursement

Tags: Warfarin, Approved, Xarelto, Latest News, UK, NHS, guidance

NICE to Assume Review of High-cost Orphan Drug Products By Alexander Gaffney - Published 23 July 2012

Categories: NICE, Reimbursement

Tags: Rawlins, AGNSS, Howe, Evaluation, HTA, CER, Latest News, NHS, Orphan Drugs

UK Proposes Reimbursement-based Accelerated Approvals Process By Alexander Gaffney - Published 17 July 2012

Categories: MHRA, Reimbursement

Tags: Scientific Opinion, Accelerated Approval, Approvals, Latest News, UK, NHS